Add to ORKGFluoroquinolones as treatment for patients with lower respiratory tract infections caused b
Streptococcus pneumoniae is a common bacterialpathogen in many adult respiratory tract infections, i...
Summary: The global emergence of Streptococcus pneumoniae resistance to fluoroquinolones is alarming...
The incidence of antimicrobial-resistant strains of Streptococcus pneumoniae has increased alarmingl...
Newer fluoroquinolones such as levofloxacin, moxifloxacin, gatifloxacin and gemifloxacin have severa...
Lower respiratory tract infection is a common condition associated with considerable morbidity and m...
The role of the new fluoroquinolones in the treatment of lower respiratory tract infec-tions is stil...
antimicrobial agents. pneumoniae with resistance to other compounds against strains of Streptococcus...
This review focuses on the activity of gemifloxacin, a new respiratory fluoroquinolone, against the ...
The respiratory fluoroquinolones are considered to be an effective treatment option for community-ac...
Contains fulltext : mmubn000001_051426331.pdf (publisher's version ) (Open Access)...
Streptococcus pneumoniae is a well-known agent of community-acquired infections such as sinusitis, o...
LIMOGES-BU Médecine pharmacie (870852108) / SudocLYON1-BU Santé (693882101) / SudocSudocFranceF
is a common and important disease that occurs in all age groups worldwide. Strep-tococcus pneumoniae...
As part of the SENTRY antimicrobial resistance surveillance program, a total of 1100 clinically sign...
Community-acquired pneumonia is one of the most prevalent infectious diseases and there are numerous...
Streptococcus pneumoniae is a common bacterialpathogen in many adult respiratory tract infections, i...
Summary: The global emergence of Streptococcus pneumoniae resistance to fluoroquinolones is alarming...
The incidence of antimicrobial-resistant strains of Streptococcus pneumoniae has increased alarmingl...
Newer fluoroquinolones such as levofloxacin, moxifloxacin, gatifloxacin and gemifloxacin have severa...
Lower respiratory tract infection is a common condition associated with considerable morbidity and m...
The role of the new fluoroquinolones in the treatment of lower respiratory tract infec-tions is stil...
antimicrobial agents. pneumoniae with resistance to other compounds against strains of Streptococcus...
This review focuses on the activity of gemifloxacin, a new respiratory fluoroquinolone, against the ...
The respiratory fluoroquinolones are considered to be an effective treatment option for community-ac...
Contains fulltext : mmubn000001_051426331.pdf (publisher's version ) (Open Access)...
Streptococcus pneumoniae is a well-known agent of community-acquired infections such as sinusitis, o...
LIMOGES-BU Médecine pharmacie (870852108) / SudocLYON1-BU Santé (693882101) / SudocSudocFranceF
is a common and important disease that occurs in all age groups worldwide. Strep-tococcus pneumoniae...
As part of the SENTRY antimicrobial resistance surveillance program, a total of 1100 clinically sign...
Community-acquired pneumonia is one of the most prevalent infectious diseases and there are numerous...
Streptococcus pneumoniae is a common bacterialpathogen in many adult respiratory tract infections, i...
Summary: The global emergence of Streptococcus pneumoniae resistance to fluoroquinolones is alarming...
The incidence of antimicrobial-resistant strains of Streptococcus pneumoniae has increased alarmingl...